搜索临床试验以:比利亚尔塔电话得分 < 5
总计32个结果
-
Association des Médecins Vasculaires HospitaliersSanofi; Ministry of Health, France; Daiichi Sankyo, Inc.; LEO Pharma; University Hospital, Grenoble完全的
-
Bournemouth University完全的
-
M.D. Anderson Cancer CenterAriad Pharmaceuticals撤销白血病 | FLT3-突变型急性髓性白血病 | FLT3-突变型高危骨髓增生异常综合征
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbH完全的
-
Groupe Français de Pneumo-CancérologieAstraZeneca主动,不招人
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)完全的
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR)完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University; Helsinn Therapeutics (U.S.), Inc完全的
-
Jonsson Comprehensive Cancer CenterArcus Biosciences, Inc.暂停
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)主动,不招人
-
Gruppo Oncologico del Nord-OvestRoche Pharma AG完全的
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Cliniques universitaires Saint-Luc- Université Catholique de Louvain完全的
-
Fundación Pública Andaluza Progreso y SaludInstituto de Salud Carlos III未知
-
Mehrdad Abedi, MDNational Cancer Institute (NCI)招聘中
-
Mayo ClinicNational Cancer Institute (NCI)招聘中复发性霍奇金淋巴瘤 | 慢性粒单核细胞白血病 | 难治性淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 复发性淋巴瘤 | 意义未明的克隆性血细胞减少症 | 具有 MYC 和 BCL2 或 BCL6 重排的高级别 B 细胞淋巴瘤美国